EP 1740161 A2 20070110 - TRANSDERMAL SYSTEM SECURED AGAINST MISUSE
Title (en)
TRANSDERMAL SYSTEM SECURED AGAINST MISUSE
Title (de)
GEGEN MISSBRAUCH GESICHERTES TRANSDERMALES SYSTEM
Title (fr)
SYSTEME TRANSDERMIQUE SECURISE CONTRE UNE UTILISATION NON CONFORME
Publication
Application
Priority
- EP 2005004280 W 20050421
- DE 102004019916 A 20040421
Abstract (en)
[origin: WO2005102294A2] The invention relates to a transdermal system which is secured against misuse. Said system contains, in addition to one or several active substances having misuse potential, at least one gel-forming agent in such an amount that it forms a gel having a minimum amount of an aqueous liquid. It also contains, as additional misuse aggravating and/or preventing agents, at least one emetic and/or at least one colorant as aversive agents.
IPC 8 full level
A61K 9/70 (2006.01); A61K 31/485 (2006.01)
CPC (source: EP US)
A61K 9/7061 (2013.01 - EP US)
Citation (examination)
- WO 03090729 A1 20031106 - JOHNSON & JOHNSON C O ALZA COR [US]
- DE 10250083 A1 20031224 - GRUENENTHAL GMBH [DE]
- WO 03013479 A1 20030220 - EURO CELTIQUE SA [LU], et al
- PARFITT, K: "Martindale. The complete drug reference. 32nd edition.", 1999, PHARMACEUTICAL PRESS, London, article "Naltrexone hydrochloride", pages: 988 - 988
- JAMES SWARBRICK (ED.): "Encyclopedia of Pharmaceutical Technology. Third Edition.", vol. 3, 2000, INFORMA HEALTHCARE, New York, London, ISBN: 9780849393945, article C.M. OFNER AND C.M. KLECH-GELOTTE: "Gel and Jellies", pages: 1875 - 1890
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
LV
DOCDB simple family (publication)
WO 2005102294 A2 20051103; WO 2005102294 A3 20060518; DE 102004019916 A1 20051117; EP 1740161 A2 20070110; US 2007065365 A1 20070322
DOCDB simple family (application)
EP 2005004280 W 20050421; DE 102004019916 A 20040421; EP 05735106 A 20050421; US 58380806 A 20061020